ArticleMolecular therapy. Methods & clinical development2018

Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.

Joni Keto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.